0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Macrophage cytoplasmic vesicle pH gradients and vacuolar H+-ATPase activities relative to virus infection.

      1 ,
      Journal of leukocyte biology
      Wiley

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A number of viruses replicate in macrophages, some having an obligate requirement for a macrophage host. This raised the question concerning the role of the macrophage endosomal/lysosomal compartment during such infections. Both lysosomotropic weak bases, amantadine and chloroquine, which interfere with endosomal/lysosomal pH gradients, and the macrolide antibiotic bafilomycin A1, which interferes with vacuolar H+-ATPase, inhibited African swine fever (ASF) virus replication in porcine macrophages. This inhibition was reversible: replenishment of bafilomycin, but not amantadine or chloroquine, maintained the inhibition. The characteristics of the inhibition, and the capacity of virus to escape and re-commence replication, related to the capacity of each drug to interfere with the endosomal/lysosomal proton pump. These results demonstrate that the virus actually requires macrophage endosomal/lysosomal activity for its replication. Therein, vacuolar H+-ATPase activity is particularly critical for successful virus replication, which is interesting considering the importance of this for endosomal/lysosomal activity and macrophage function.

          Related collections

          Author and article information

          Journal
          J. Leukoc. Biol.
          Journal of leukocyte biology
          Wiley
          0741-5400
          0741-5400
          Sep 1998
          : 64
          : 3
          Affiliations
          [1 ] Institute of Virology and Immunoprophylaxis, Mittelhäusern, Switzerland.
          Article
          10.1002/jlb.64.3.302
          9738656
          c42bb21e-dd22-4f67-913d-4c90177d44cf
          History

          Comments

          Comment on this article